Top

16-02-2018 | Osteoarthritis | Review | Article

Recent advances in hyaluronic acid based therapy for osteoarthritis

Journal: Clinical and Translational Medicine

Authors: Steven Bowman, Mohamed E. Awad, Mark W. Hamrick, Monte Hunter, Sadanand Fulzele

Publisher: Springer Berlin Heidelberg

Abstract

Osteoarthritis is a debilitating disease that has increased in prevalence across the world due to the aging population. Currently, physicians use a plethora of treatment strategies to try and slow down the progression of the disease, but none have been shown to ubiquitously treat and cure the disease. One of the strategies uses the high molecular weight molecule hyaluronic acid as either an injectable or oral supplement for treatment. Hyaluronic acid (HA) is a relatively new treatment that has shown varied results through several clinical trials. It can be used as a scaffold for engineering new treatments and several new preparations have just been added to the market. A comprehensive search was conducted through several search databases according our inclusion and exclusion criteria. This review included 44 prospective clinical trial investigating the feasibility and efficacy of HA injection for knee, hip, and ankle osteoarthritis. This review will take a closer look at hyaluronic acid and its properties, as well clinical effectiveness and future options.

Berenbaum F (2013) Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthr Cartil 21(1):16–21PubMedCrossRef

CDC (2013) Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2010–2012. MMWR 62:869–873

Barbour K et al (2014) Meeting physical activity guidelines and the risk of incident knee osteoarthritis: the Johnston County Osteoarthritis Project. Arthritis Care Res (Hoboken) 66(1):139–146PubMedCentralCrossRef

Moskowitz RW (2009) The burden of osteoarthritis: clinical and quality-of-life issues. Am J Manag Care 15(8 Suppl):S223–S229PubMed

Puig-Junoy J, Ruiz Zamora A (2015) Socio-economic costs of osteoarthritis: a systematic review of cost-of-illness studies. Semin Arthritis Rheum 44(5):531–541PubMedCrossRef

Herrero-Beaumont G et al (2017) Clinical settings in knee osteoarthritis: pathophysiology guides treatment. Maturitas 96:54–57PubMedCrossRef

Zhang W et al (2008) OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 16(2):137–162PubMedCrossRef

Osteoarthritis Fact Sheet (2017) https://www.cdc.gov/arthritis/basics/osteoarthritis.htm. Accessed 24 May 2017

Brosseau L et al (2017) The Ottawa panel clinical practice guidelines for the management of knee osteoarthritis. Part one: introduction, and mind-body exercise programs. Clin Rehabil 31(5):582–595PubMedCrossRef

10.

Brosseau L et al (2017) The Ottawa panel clinical practice guidelines for the management of knee osteoarthritis. Part two: strengthening exercise programs. Clin Rehabil 31(5):596–611PubMedCrossRef

11.

Brosseau L et al (2017) The Ottawa panel clinical practice guidelines for the management of knee osteoarthritis. Part three: aerobic exercise programs. Clin Rehabil 31(5):612–624PubMedCrossRef

12.

Brien S, Prescott P, Lewith G (2011) Meta-analysis of the related nutritional supplements dimethyl sulfoxide and methylsulfonylmethane in the treatment of osteoarthritis of the knee. Evid Based Complement Alternat Med 2011:528403PubMedPubMedCentral

13.

Crofford LJ (2013) Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther 15(Suppl 3):S2PubMedPubMedCentral

14.

da Costa BR et al (2016) Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet 387(10033):2093–2105PubMedCrossRef

15.

Iannitti T, Lodi D, Palmieri B (2011) Intra-articular injections for the treatment of osteoarthritis: focus on the clinical use of hyaluronic acid. Drugs R&D 11(1):13–27CrossRef

16.

Balazs EA et al (1967) Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum 10(4):357–376PubMedCrossRef

17.

Laurent TC, Laurent UB, Fraser JR (1996) The structure and function of hyaluronan: an overview. Immunol Cell Biol 74(2):A1–A7PubMedCrossRef

18.

Altman RD et al (2015) The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord 16:321PubMedPubMedCentralCrossRef

19.

Ayhan E, Kesmezacar H, Akgun I (2014) Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop 5(3):351–361PubMedPubMedCentralCrossRef

20.

Stern R, Jedrzejas MJ (2006) Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev 106(3):818–839PubMedPubMedCentralCrossRef

21.

Oe M et al (2015) Oral hyaluronan relieves knee pain: a review. Nutr J 15:11CrossRef

22.

Moreland LW (2003) Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 5(2):54–67PubMedPubMedCentralCrossRef

23.

Bannuru RR et al (2011) Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis—meta-analysis. Osteoarthritis Cartilage 19(6):611–619PubMedCrossRef

24.

Cooper C, Rannou F, Richette P, Bruyère O, Al-Daghri N, Altman RD, Brandi ML, Collaud Basset S, Herrero-Beaumont G, Migliore A, Pavelka K, Uebelhart D, Reginster JY (2017) Use of intraarticular hyaluronic acid in the management of knee osteoarthritis in clinical practice. Arthritis Care Res (Hoboken) 69(9):1287–1296CrossRef

25.

Hisada N et al (2008) Low-molecular-weight hyaluronan permeates through human intestinal Caco-2 cell monolayers via the paracellular pathway. Biosci Biotechnol Biochem 72(4):1111–1114PubMedCrossRef

26.

Asari A, Kanemitsu T, Kurihara H (2010) Oral administration of high molecular weight hyaluronan (900 kDa) controls immune system via Toll-like receptor 4 in the intestinal epithelium. J Biol Chem 285(32):24751–24758PubMedPubMedCentralCrossRef

27.

Tashiro T et al (2012) Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis: a double-blind, placebo-controlled study over a 12-month period. Sci World J 2012:167928CrossRef

28.

Shewale AR, Barnes CL, Fischbach LA, Ounpraseuth ST, Painter JT, Martin BC (2017) Comparison of low-, moderate-, and high-molecular-weight hyaluronic acid injections in delaying time to knee surgery. J Arthroplasty 32(10):2952–2957.e21PubMedCrossRef

29.

Balazs EA (2004) Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results. Surg Technol Int 12:278–289PubMed

30.

Bellamy N et al (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 19(2):Cd005321

31.

Nguyen C, Rannou F (2017) The safety of intra-articular injections for the treatment of knee osteoarthritis: a critical narrative review. Expert Opin Drug Saf 16(8):897–902PubMedCrossRef

32.

Ricci M et al (2017) Clinical comparison of oral administration and viscosupplementation of hyaluronic acid (HA) in early knee osteoarthritis. Musculoskelet Surg 101(1):45–49PubMedCrossRef

33.

Panuccio E, Memeo A, Richetta S (2015) Evaluation of the combined treatment of oral viscosupplementation with hyaluronic acid intra-articular injection on symptomatic knee osteoarthritis. Clin Ter 166(5):e321–e326PubMed

34.

Baier Leach J et al (2003) Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng 82(5):578–589PubMedCrossRef

35.

Xu X et al (2012) Hyaluronic acid-based hydrogels: from a Natural Polysaccharide to Complex Networks. Soft Matter 8(12):3280–3294PubMedPubMedCentralCrossRef

36.

Fakhari A (2012) Biomedical application of hyaluronic acid nanoparticles. PhD thesis

37.

Burdick JA, Prestwich GD (2011) Hyaluronic acid hydrogels for biomedical applications. Adv Mater 23(12):H41–H56PubMedPubMedCentralCrossRef

38.

Collins MN, Birkinshaw C (2013) Hyaluronic acid based scaffolds for tissue engineering—A review. Carbohyd Polym 92(2):1262–1279CrossRef

39.

Yoshioka K et al (2014) Pharmacological effects of novel cross-linked hyaluronate, Gel-200, in experimental animal models of osteoarthritis and human cell lines. Osteoarthr Cartil 22(6):879–887PubMedCrossRef

40.

Sun SF et al (2017) Comparison of single intra-articular injection of novel hyaluronan (HYA-JOINT Plus) with synvisc-one for knee osteoarthritis: a Randomized, Controlled, Double-Blind Trial of Efficacy and Safety. J Bone Joint Surg Am 99(6):462–471PubMedCrossRef

41.

Hangody L et al. Intraarticular injection of a cross-linked sodium hyaluronate combined with triamcinolone hexacetonide (cingal) to provide symptomatic relief of osteoarthritis of the knee: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Trial. Cartilage, 2017: 1947603517703732

42.

Park YB et al (2017) Cartilage regeneration in osteoarthritic patients by a composite of allogeneic umbilical cord blood-derived mesenchymal stem cells and hyaluronate hydrogel: results from a clinical trial for safety and proof-of-concept with 7 years of extended follow-Up. Stem Cells Transl Med 6(2):613–621PubMedCrossRef

43.

Waddell DD, Bricker DC (2007) Total knee replacement delayed with Hylan G-F 20 use in patients with grade IV osteoarthritis. J Manag Care Pharm 13(2):113–121PubMed

44.

Altman RD et al (2004) Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthr Cartil 12(8):642–649PubMedCrossRef

45.

Lundsgaard C et al (2008) Intra-articular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trial. Scand J Rheumatol 37(2):142–150PubMedCrossRef

46.

Karatosun V et al (2005) Comparison of two hyaluronan drugs in patients with advanced osteoarthritis of the knee. A prospective, randomized, double-blind study with long term follow-up. Clin Exp Rheumatol 23(2):213–218PubMed

47.

Xing D, Wang B, Liu Q, Ke Y, Xu Y, Li Z, Lin J (2016) Intra-articular hyaluronic acid in treating knee osteoarthritis: a PRISMA-compliant systematic review of overlapping meta-analysis. Sci Rep 6:32790PubMedPubMedCentralCrossRef

48.

Brandt KD et al (2001) Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop Relat Res 385:130–143CrossRef

49.

Day R et al (2004) A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol 31(4):775–782PubMed

50.

Neustadt D et al (2005) Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial. J Rheumatol 32(10):1928–1936PubMed

51.

Cubukcu D et al (2005) Hylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clin Rheumatol 24(4):336–341PubMedCrossRef

52.

Petrella RJ, Petrella M (2006) A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol 33(5):951–956PubMed

53.

Huskisson EC, Donnelly S (1999) Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology 38(7):602–607PubMedCrossRef

54.

Altman RD et al (2011) Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study of the FLEXX Trial. Osteoarthr Cartil 19(10):1169–1175PubMedCrossRef

55.

Huang TL et al (2011) Intra-articular injections of sodium hyaluronate (Hyalgan(^®)) in osteoarthritis of the knee. A randomized, controlled, double-blind, multicenter trial in the asian population. BMC Musculoskelet Disord 12:221PubMedPubMedCentralCrossRef

56.

Dasa V, DeKoven M, Sun K, Scott A, Lim S (2016) Clinical and cost outcomes from different hyaluronic acid treatments in patients with knee osteoarthritis: evidence from a US health plan claims database. Drugs Context 5:212296PubMedPubMedCentralCrossRef

57.

Battaglia M et al (2013) Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis. Orthopedics 36(12):e1501–e1508PubMedCrossRef

58.

Vad VB et al (2003) Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil 84(8):1224–1226PubMedCrossRef

59.

Migliore A et al (2009) Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix(^®)) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Res Ther 11(6):R183PubMedPubMedCentralCrossRef

60.

Piccirilli E et al (2016) Viscosupplementation with intra-articular hyaluronic acid for hip disorders. A systematic review and meta-analysis. Muscles Ligaments Tendons J 6(3):293–299PubMedPubMedCentral

61.

Chang KV et al (2013) Effectiveness of intra-articular hyaluronic acid for ankle osteoarthritis treatment: a systematic review and meta-analysis. Arch Phys Med Rehabil 94(5):951–960PubMedCrossRef

62.

Mei-Dan O et al (2013) Intra-articular injections of hyaluronic acid in osteoarthritis of the subtalar joint: a pilot study. J Foot Ankle Surg 52(2):172–176PubMedCrossRef

63.

Rivera F et al (2016) Effectiveness of intra-articular injections of sodium hyaluronate-chondroitin sulfate in knee osteoarthritis: a multicenter prospective study. J Orthop Traumatol 17(1):27–33PubMedCrossRef

64.

Xin Y et al (2016) The efficacy and safety of sodium hyaluronate injection (Adant(^®)) in treating degenerative osteoarthritis: a multi-center, randomized, double-blind, positive-drug parallel-controlled and non-inferiority clinical study. Int J Rheum Dis 19(3):271–278PubMedCrossRef

65.

Foti C et al (2011) A prospective observational study of the clinical efficacy and safety of intra-articular sodium hyaluronate in synovial joints with osteoarthritis. Eur J Phys Rehabil Med 47(3):407–415PubMed

66.

67.

Şükür E et al (2016) Comparison of the chondroprotective effect of a novel hydrogel compound and traditional hyaluronate on rat cartilage in a papain-induced osteoarthritis model. Acta Orthopaedica et Traumatologica Turcica 50(4):458–463PubMedCrossRef

68.

Tamura T et al (2016) Novel hyaluronic acid–methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models. Arthritis Res Ther 18:79PubMedPubMedCentralCrossRef

69.

Ishikawa M et al (2014) Biocompatibility of cross-linked hyaluronate (Gel-200) for the treatment of knee osteoarthritis. Osteoarthr Cartil 22(11):1902–1909PubMedCrossRef

70.

Zille H et al (2010) Evaluation of intra-articular delivery of hyaluronic acid functionalized biopolymeric nanoparticles in healthy rat knees. Biomed Mater Eng 20(3):235–242PubMed

71.

Morgen M et al (2013) Nanoparticles for improved local retention after intra-articular injection into the knee joint. Pharm Res 30(1):257–268PubMedCrossRef

72.

McAlindon TE et al (2014) OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 22(3):363–388PubMedCrossRef

73.

Hochberg MC et al (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 64(4):465–474CrossRef

74.

Gigis I et al (2016) Comparison of two different molecular weight intra-articular injections of hyaluronic acid for the treatment of knee osteoarthritis. Hippokratia 20(1):26–31PubMedPubMedCentral

75.

Berg P, Olsson U (2004) Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol 22(3):300–306PubMed

76.

Caglar-Yagci H et al (2005) Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study. Rheumatol Int 25(5):341–344PubMedCrossRef

77.

Tikiz C et al (2005) Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumatol 24(3):244–250PubMedCrossRef

78.

Qvistgaard E et al (2006) Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage 14(2):163–170PubMedCrossRef

79.

Gaston MS, Tiemessen CH, Philips JE (2007) Intra-articular hip viscosupplementation with synthetic hyaluronic acid for osteoarthritis: efficacy, safety and relation to pre-injection radiographs. Arch Orthop Trauma Surg 127(10):899–903PubMedCrossRef

80.

Rennesson-Rey B, Rat AC, Chary-Valckenaere I, Bettembourg-Brault I, Juge N, Dintinger H, Pourel J, Loeuille D (2008) Does joint effusion influence the clinical response to a single Hylan GF-20 injection for hip osteoarthritis? Joint Bone Spine 75(2):182–188PubMedCrossRef

81.

Richette P et al (2009) Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial. Arthritis Rheum 60(3):824–830PubMedCrossRef

82.

Spitzer AI, Bockow BI, Brander VA, Yates JW, MacCarter DK, Gudger GK, Haller S, Lake SL, Magilavy DB (2010) Hylan G-F 20 improves hip osteoarthritis: a prospective, randomized study. Phys Sportsmed 38(2):35–47PubMedCrossRef

83.

Eyigor C et al (2010) Efficacy of intraarticular hyaluronic acid injection through a lateral approach under fluoroscopic control for advanced hip osteoarthritis. Agri 22(4):139–144PubMed

84.

Atchia I et al (2011) Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis. Ann Rheum Dis 70(1):110–116PubMedCrossRef

85.

Dallari D et al (2016) Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: a Randomized Controlled Study. Am J Sports Med 44(3):664–671PubMedCrossRef

86.

DeGroot H 3rd et al (2012) Intra-articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double-blind, placebo-controlled study. J Bone Joint Surg Am 94(1):2–8PubMedCrossRef

87.

Cohen MM et al (2008) Safety and efficacy of intra-articular sodium hyaluronate (Hyalgan) in a randomized, double-blind study for osteoarthritis of the ankle. Foot Ankle Int 29(7):657–663PubMedCrossRef

88.

Salk RS et al (2006) Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Joint Surg Am 88(2):295–302PubMed

89.

Karatosun V et al (2008) Intra-articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long-term follow-up. Clin Exp Rheumatol 26(2):288–294PubMed

90.

Carpenter B, Motley T (2008) The role of viscosupplementation in the ankle using hylan G-F 20. J Foot Ankle Surg 47(5):377–384PubMedCrossRef

91.

Sun SF et al (2006) Efficacy of intra-articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthr Cartil 14(9):867–874PubMedCrossRef

92.

Luciani D et al (2008) Viscosupplementation for grade II osteoarthritis of the ankle: a prospective study at 18 months’ follow-up. Chir Organi Mov 92(3):155–160PubMedCrossRef

93.

Witteveen AG et al (2008) A prospective multi-centre, open study of the safety and efficacy of hylan G-F 20 (Synvisc) in patients with symptomatic ankle (talo-crural) osteoarthritis. Foot Ankle Surg 14(3):145–152PubMedCrossRef

94.

Sun SF et al (2011) The effect of 3 weekly intra-articular injections of hyaluronate on pain, function, and balance in patients with unilateral ankle arthritis. J Bone Joint Surg Am 93(18):1720–1726PubMedCrossRef

95.

Grecomoro G, Martorana U, Di Marco C (1987) Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica 5(2):137–141PubMed

96.

Puhl W et al (1993) Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthr Cartil 1(4):233–241PubMedCrossRef

97.

Henderson EB et al (1994) Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis 53(8):529–534PubMedPubMedCentralCrossRef

98.

Adams ME et al (1995) The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthr Cartil 3(4):213–225PubMedCrossRef

99.

Lohmander LS et al (1996) Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 55(7):424–431PubMedPubMedCentralCrossRef

100.

Bunyaratavej N, Chan KM, Subramanian N (2001) Treatment of painful osteoarthritis of the knee with hyaluronic acid. Results of a multicenter Asian study. J Med Assoc Thai 84(Suppl 2):S576–S581PubMed

101.

Jubb RW et al (2003) A one-year, randomised, placebo (saline) controlled clinical trial of 500–730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract 57(6):467–474PubMed

102.

Chevalier X et al (2010) Single, intra-articular treatment with 6 mL hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis 69(1):113–119PubMedCrossRef

103.

Petrella RJ, DiSilvestro MD, Hildebrand C (2002) Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 162(3):292–298PubMedCrossRef

104.

Strand V et al (2012) A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee. Osteoarthr Cartil 20(5):350–356PubMedCrossRef

Medicine Matters Rheumatology

Abstract